Cilazapril Inhibits the Upregulated Endothelin System in the Kidney of Diabetic Hypertensive Rats

陈靖,顾勇,杨海春,朱蔚钰,林凡,林善锬
DOI: https://doi.org/10.3969/j.issn.1672-8467.2002.01.006
2002-01-01
Abstract:Purpose To investigate the changes of endothelin (ET) system in the kidney of spontaneously hypertensive rats (SHR) with diabetes and the influence of ACEI. Methods Streptozotocin induced diabetic SHR were divided into cilazapril treated group,amlodipine treated group,and untreated group.SHR and WKY rats were regarded as hypertensive and normotensive control group,respectively.The mean arterial blood pressure,urinary protein excretion,creatinine clearance,plasma and renal endothelin as well as renal expression of endothelin 1 and its receptors were determined at the end of 4th week. Results Both antihypertensive therapies attenuated the rise in blood pressure of untreated diabetic SHR.The enhanced urinary protein excretion and decreased creatinine clearance as well as increased plasma and renal endothelin levels were also observed in untreated diabetic SHR compared to WKY rats.Immunohistochemistry and RT?PCR method showed that the amount of protein and mRNA expression of ET?1 and type A receptor in the kidney were significantly increased in untreated diabetic SHR compared with those in WKY rats.However,endothelin type B type receptor expression were not altered in the kidney from all groups.All these abnormalities were obviously ameliorated by cilazapril. Conclusions Cilazapril could effectively inhibit the upregulated ET system in the kidney of diabetic SHR.
What problem does this paper attempt to address?